EG110A preclinical results - ICS 2023
Presentation and Abstract publication during International Continence Society conference 2023.
INTRAVESICAL ADMINISTRATION OF EG110A, A NOVEL NON-REPLICATIVE HERPES SIMPLEX VIRUS TYPE 1 (HSV1)-DERIVED VECTOR EXPRESSING THE LIGHT CHAIN OF BOTULINUM TOXIN F, INHIBITS C-TYPE FIBERS IN AN ACUTE INTRAVESICAL CAPSAICIN RAT MODEL